Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8722053rdf:typepubmed:Citationlld:pubmed
pubmed-article:8722053lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0035309lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0020616lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:8722053lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:8722053pubmed:issue12lld:pubmed
pubmed-article:8722053pubmed:dateCreated1996-10-11lld:pubmed
pubmed-article:8722053pubmed:abstractTextIn insulin-dependent diabetes mellitus, institution of good glycemic control has been shown to retard development of retinopathy even though temporary progression has occurred. Few data have been available from patients with non-insulin-dependent diabetes mellitus (NIDDM). To determine the impact of improved glycemic control on retinopathy in patients with NIDDM, we examined, in a case-control study, the progression of retinopathy in 94 patients who changed treatment from oral antihyperglycemic agents to insulin.lld:pubmed
pubmed-article:8722053pubmed:languageenglld:pubmed
pubmed-article:8722053pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:citationSubsetIMlld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8722053pubmed:statusMEDLINElld:pubmed
pubmed-article:8722053pubmed:monthDeclld:pubmed
pubmed-article:8722053pubmed:issn0149-5992lld:pubmed
pubmed-article:8722053pubmed:authorpubmed-author:JanzonLLlld:pubmed
pubmed-article:8722053pubmed:authorpubmed-author:GroopLLlld:pubmed
pubmed-article:8722053pubmed:authorpubmed-author:HenricssonMMlld:pubmed
pubmed-article:8722053pubmed:issnTypePrintlld:pubmed
pubmed-article:8722053pubmed:volume18lld:pubmed
pubmed-article:8722053pubmed:ownerNLMlld:pubmed
pubmed-article:8722053pubmed:authorsCompleteYlld:pubmed
pubmed-article:8722053pubmed:pagination1571-6lld:pubmed
pubmed-article:8722053pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:meshHeadingpubmed-meshheading:8722053-...lld:pubmed
pubmed-article:8722053pubmed:year1995lld:pubmed
pubmed-article:8722053pubmed:articleTitleProgression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.lld:pubmed
pubmed-article:8722053pubmed:affiliationDepartment of Ophthalmology, Helsingborg Hospital, Sweden.lld:pubmed
pubmed-article:8722053pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8722053pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8722053pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8722053lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8722053lld:pubmed